| Current Price | $45.52 | Mkt Cap | $2.2B |
|---|---|---|---|
| Open | $49.29 | P/E Ratio | 0.00 |
| Prev. Close | $50.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $45.15 - $50.07 | Volume | 2,154,024 |
| 52-Wk Range | $20.63 - $71.98 | Avg. Daily Vol. | 1,793,353 |
| Current Price | $45.52 | Mkt Cap | $2.2B |
|---|---|---|---|
| Open | $49.29 | P/E Ratio | 0.00 |
| Prev. Close | $50.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $45.15 - $50.07 | Volume | 2,154,024 |
| 52-Wk Range | $20.63 - $71.98 | Avg. Daily Vol. | 1,793,353 |
The best Bull and Bear pitches based on recency and number of recommendations.
Biotech company stock dropped due to company does not participate in the Covid vaccine race. They should be really successful after their anti-depression drugs are approved
CNS diseases with patient-reported outcomes are so difficult to show efficacy.
Read the most recent pitches from players about AXSM.
Recs
TMFAdriaCimino
(< 20)
Submitted: 9/13/2022 2:40:57 PM :
Start Price:
$60.23
NASDAQ:AXSM Score:
-16.14
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth drivers that are at the beginning of their story.
Recs
TMFjimhalley
(< 20)
Submitted: 5/12/2022 1:07:26 PM :
Start Price:
$24.94
NASDAQ:AXSM Score:
+89.98
The company should benefit from revenue from Sunosi, as well as AXS-05, when that drug is approved.
Recs
folge
(< 20)
Submitted: 5/2/2022 3:54:45 PM :
Start Price:
$34.10
NASDAQ:AXSM Score:
+46.09
They're about to commercialize the world's next blockbuster drug - AXS-05 - and have many others with positive testing results.
Find the members with the highest scoring picks in AXSM.
jeepdrew222 (58.73) Score: +1,633.77
The Score Leader is the player with the highest score across all their picks in AXSM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jeepdrew222 | 58.73 | 8/27/2018 |
|
5Y | $2.60 | +1,660.19% | +26.42% | +1,633.77 | 0 Comment | |
|
Under5 | 54.74 |
|
|
5Y | $2.60 | +1,660.19% | +40.02% | +1,620.17 | 0 Comment |
| NextGenStock | < 20 | 6/20/2018 |
|
5Y | $3.00 | +1,425.50% | +32.18% | +1,393.32 | 0 Comment | |
| NateVDM214 | < 20 | 6/21/2018 |
|
3Y | $3.15 | +1,352.86% | +32.33% | +1,320.53 | 0 Comment | |
| jumbofaceplate | < 20 | 5/15/2017 |
|
5Y | $4.10 | +1,016.22% | +52.49% | +963.73 | 0 Comment | |
|
|
ababrmon | 30.23 | 1/2/2018 |
|
5Y | $5.47 | +736.84% | +36.11% | +700.73 | 0 Comment |
| warmwind | < 20 | 1/13/2017 |
|
5Y | $5.50 | +732.09% | +61.06% | +671.03 | 0 Comment | |
| clangmead | 37.62 | 1/15/2019 |
|
5Y | $7.52 | +508.58% | +41.64% | +466.94 | 0 Comment | |
| Reallynow222 | 92.59 | 2/28/2019 |
|
5Y | $8.20 | +458.11% | +30.78% | +427.33 | 0 Comment | |
| Momentum21 | 78.50 | 6/2/2016 |
|
5Y | $7.68 | +495.90% | +73.68% | +422.21 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
